Gainers
- P3 Health Partners PIII shares increased by 43.8% to $0.31 during Tuesday's pre-market session. The company's market cap stands at $50.3 million.
- Immuron IMRN stock increased by 22.33% to $2.41. The market value of their outstanding shares is at $13.7 million.
- Co-Diagnostics CODX shares rose 21.12% to $0.92. The market value of their outstanding shares is at $29.4 million.
- Regenxbio RGNX stock rose 17.26% to $8.15. The company's market cap stands at $403.7 million.
- Atara Biotherapeutics ATRA stock rose 15.44% to $18.69. The market value of their outstanding shares is at $107.6 million.
- Abpro Hldgs ABP stock increased by 12.3% to $1.46. The market value of their outstanding shares is at $75.6 million.
Losers
- Phio Pharma PHIO shares declined by 42.7% to $3.78 during Tuesday's pre-market session. The company's market cap stands at $6.5 million.
- Avinger AVGR shares fell 21.56% to $0.63. The company's market cap stands at $2.0 million.
- Agape ATP ATPC shares fell 21.32% to $1.55. The company's market cap stands at $6.1 million.
- Salarius Pharmaceuticals SLRX stock decreased by 21.26% to $2.89. The market value of their outstanding shares is at $4.1 million.
- Anitra AZTR shares decreased by 14.8% to $0.49. The market value of their outstanding shares is at $3.7 million.
- GT Biopharma GTBP shares decreased by 12.98% to $2.08. The market value of their outstanding shares is at $4.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ATPCAgape ATP Corp
$1.53-22.3%
ATRAAtara Biotherapeutics Inc
$18.7916.1%
AVGRAvinger Inc
$0.6549-18.4%
AZTRAzitra Inc
$0.5085-11.6%
CODXCo-Diagnostics Inc
$0.923021.1%
GTBPGT Biopharma Inc
$2.08-13.0%
IMRNImmuron Ltd
$2.2916.2%
PHIOPhio Pharmaceuticals Corp
$5.39-18.3%
PIIIP3 Health Partners Inc
$0.301540.3%
RGNXRegenxbio Inc
$8.1317.0%
SLRXSalarius Pharmaceuticals Inc
$2.84-22.6%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in